1. Home
  2. EVTC vs MPLT Comparison

EVTC vs MPLT Comparison

Compare EVTC & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evertec Inc.

EVTC

Evertec Inc.

HOLD

Current Price

$31.38

Market Cap

1.8B

Sector

Technology

ML Signal

HOLD

Logo MapLight Therapeutics Inc.

MPLT

MapLight Therapeutics Inc.

HOLD

Current Price

$11.97

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVTC
MPLT
Founded
1988
2018
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.7B
IPO Year
2013
2025

Fundamental Metrics

Financial Performance
Metric
EVTC
MPLT
Price
$31.38
$11.97
Analyst Decision
Hold
Strong Buy
Analyst Count
5
7
Target Price
$35.80
$32.67
AVG Volume (30 Days)
382.6K
1.3M
Earning Date
05-06-2026
05-28-2026
Dividend Yield
0.67%
N/A
EPS Growth
27.17
82.39
EPS
0.47
N/A
Revenue
$453,869,000.00
N/A
Revenue This Year
$12.68
N/A
Revenue Next Year
$6.86
N/A
P/E Ratio
$64.70
N/A
Revenue Growth
11.48
N/A
52 Week Low
$21.81
$9.10
52 Week High
$37.38
$40.43

Technical Indicators

Market Signals
Indicator
EVTC
MPLT
Relative Strength Index (RSI) 58.40 28.90
Support Level $27.98 $11.56
Resistance Level $34.41 $20.73
Average True Range (ATR) 1.31 1.73
MACD -0.18 -0.36
Stochastic Oscillator 46.43 38.88

Price Performance

Historical Comparison
EVTC
MPLT

About EVTC Evertec Inc.

Evertec Inc is a transaction processing business in Latin America and the Caribbean. Its business segments are Merchant Acquiring, Payment Services - Puerto Rico & Caribbean, Latin America Payments and Solutions, and Business Solutions. Latin America Payments and Solutions segment derive maximum revenue. The company serves a diversified customer base of financial institutions, merchants, corporations, and government agencies with mission-critical technology solutions that enable them to issue, process, and accept transactions securely. Geographically, it operates in Puerto Rico, Caribbean, and Latin America.

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.

Share on Social Networks: